Efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of depression: Study protocol for a randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Wang, Huaning ^a   Xue, Yunyun ^a   Chen, Yunchun ^a   Zhang, Ruiguo ^a   Wang, Huaihai ^a   Zhang, Yahong ^a   Gan, Jingli ^b   Zhang, Liyi ^c   Tan, Qingrong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b PLA No 91 Hospital   (China)

^c PLA 102 Hospital   (China)

Author keywords

Depression; Relapse; Repetitive transcranial magnetic stimulation (rTMS)

Indexed keywords

BENZODIAZEPINE; PLACEBO; VENLAFAXINE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHINA; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HAMILTON SCALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PULSE RATE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; REMISSION; SAFETY; SCREENING; SINGLE BLIND PROCEDURE; SUICIDE; TEMPERATURE; TRANSCRANIAL MAGNETIC STIMULATION; VITAL SIGN;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHINA; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOHEXANOLS; DEPRESSION; HUMANS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885507370     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-338     Document Type: Article

References (17)

1. Eccles M, Freemantle N, Mason J. North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care. North of England Anti-depressant Guideline Development Group. Fam Pract 1999, 16(2):103-111. 10.1093/fampra/16.2.103, 10381013.
2. Sparing R, Mottaghy FM. Noninvasive brain stimulation with transcranial magnetic or direct currentstimulation (TMS/tDCS) - From insights into human memory to therapy of its dysfunction. Methods 2008, 44(4):329-337. 10.1016/j.ymeth.2007.02.001, 18374276.
3. Dell'osso B, Camuri G, Castellano F, Vecchi V, Benedetti M, Bortolussi S, Altamura AC. Meta-review of metanalytic studies with repetitive transcranial magnetic stimulation (rTMS) for the treatment of major depression. Clin Pract Epidemiol Ment Health 2011, 7:167-177. 10.2174/1745017901107010167, 3227860, 22135698.
4. Charnsil C, Suttajit S, Boonyanaruthee V, Leelarphat S. An open-label study of adjunctive repetitive transcranial magnetic stimulation (rTMS) for partial remission in major depressive disorder. Int J Psychiatry Clin Pract 2012, 16(2):98-102. 10.3109/13651501.2011.632681, 22339175.
5. Pridmore S, Bruno R, Turnier-Shea Y, Reid P, Rybak M. Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol 2000, 3(2):129-134. 10.1017/S1461145700001784, 11343589.
6. Grunhaus L, Schreiber S, Dolberg OT, Polak D, Dannon PN. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 2003, 53(4):324-331. 10.1016/S0006-3223(02)01499-3, 12586451.
7. Dannon PN, Dolberg OT, Schreiber S, Grunhaus L. Three and six-month outcome following courses of either ECT or rTMS in apopulation of severely depressed individuals - preliminary report. Biol Psychiatry 2002, 51(8):687-690. 10.1016/S0006-3223(01)01274-4, 11955470.
8. Li X, Nahas Z, Anderson B, Kozel FA, George MS. Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression. Depress Anxiety 2004, 20(2):98-100. 10.1002/da.20027, 15390210.
9. Abraham G, O'Brien S. Repetitive transcranial magnetic stimulation is useful for maintenance treatment. Can J Psychiatry 2002, 47(4):386.
10. O'Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005, 66(12):1524-1528. 10.4088/JCP.v66n1205, 16401152.
11. Danjou P, Hackett D. Safety and tolerance profile of venlafaxine. Int Clin Psychopharmacol 1995, 10(Suppl 2):15-20.
12. Montgomery SA. Rapid onset of action of venlafaxine. Int Clin Psychopharmacol 1995, 10(Suppl 2):21-27.
13. Ballenger JC. Clinical evaluation of venlafaxine. J Clin Psychopharmacol 1996, 16(3 Suppl 2):29S-35S. discussion 35S-36S.
14. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3(11):e442. 10.1371/journal.pmed.0030442, 1664601, 17132052.
15. Herwig U, Lampe Y, Juengling FD, Wunderlich A, Walter H, Spitzer M, Schönfeldt-Lecuona C. Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data. J Psychiatr Res 2003, 37(4):267-275. 10.1016/S0022-3956(03)00042-6, 12765849.
16. Su TP, Huang CC, Wei IH. Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients. J Clin Psychiatry 2005, 66(7):930-937. 10.4088/JCP.v66n0718, 16013911.
17. Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul 2010, 3(4):187-199. 10.1016/j.brs.2010.07.003, 20965447.